3 potential blockbusters beyond obesity to watch

3 potential blockbusters beyond obesity to watch is a pharma and life sciences industry update from PharmaVoice. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Alexandra Pecci · 2026-08-24

Late-stage drugs in pancreatic cancer, multiple myeloma and Alzheimer’s could pair treatment advances with major commercial upside.

Source: PharmaVoice